Trial

NCT05625347

Study to Compare the Pharmacokinetics and Pharmacodynamics of ASA Powder for Oral Inhalation With Non-enteric-coated Chewable Aspirin in Adult Subjects With Obstructive or Restrictive Pulmonary Function
Phase ITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Vectura, Inc.
Collaborators
Syneos Health
Condition
Obstructive Pulmonary Function
Intervention
single dose (100 mg) of ASA
Why stopped
The pivotal study failed to meet the primary endpoint. Without a successful readout of the pivotal study, there was no longer a purpose for the supportive BORA-1A-C302 study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-03-22